Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint

Nav

General Info

Geography

India (IND)

Time period covered

01/2021 - 12/2021

Data type

Scientific literature

Keywords

Blood tests, COVID-19, Disease outbreaks, Incidence, Medical tests, Prevalence

Citation

Authors

Misra P, Kant S, Guleria R, Rai SK, WHO Unity Seroprevalence study team of AIIMS

Journal

medRxiv

Publication year

2021

Suggested citation

Misra P, Kant S, Guleria R, Rai SK, WHO Unity Seroprevalence study team of AIIMS. Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint. medRxiv. 2021.

GHDx Entry last modified on: Apr 8, 2022

Header sites

Search form

Main menu

Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint

Nav